Cargando…
mTORC2 confers neuroprotection and potentiates immunity during virus infection
Herpes simplex virus type-1 (HSV-1) causes ocular and orofacial infections. In rare cases, HSV-1 can cause encephalitis, which leads to permanent brain injuries, memory loss or even death. Host factors protect humans from viral infections by activating the immune response. However, factors that conf...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516965/ https://www.ncbi.nlm.nih.gov/pubmed/34650053 http://dx.doi.org/10.1038/s41467-021-26260-5 |
_version_ | 1784583910483558400 |
---|---|
author | Suryawanshi, Rahul K. Patil, Chandrashekhar D. Agelidis, Alex Koganti, Raghuram Ames, Joshua M. Koujah, Lulia Yadavalli, Tejabhiram Madavaraju, Krishnaraju Shantz, Lisa M. Shukla, Deepak |
author_facet | Suryawanshi, Rahul K. Patil, Chandrashekhar D. Agelidis, Alex Koganti, Raghuram Ames, Joshua M. Koujah, Lulia Yadavalli, Tejabhiram Madavaraju, Krishnaraju Shantz, Lisa M. Shukla, Deepak |
author_sort | Suryawanshi, Rahul K. |
collection | PubMed |
description | Herpes simplex virus type-1 (HSV-1) causes ocular and orofacial infections. In rare cases, HSV-1 can cause encephalitis, which leads to permanent brain injuries, memory loss or even death. Host factors protect humans from viral infections by activating the immune response. However, factors that confer neuroprotection during viral encephalitis are poorly understood. Here we show that mammalian target of rapamycin complex 2 (mTORC2) is essential for the survival of experimental animals after ocular HSV-1 infection in vivo. We find the loss of mTORC2 causes systemic HSV-1 infection due to defective innate and adaptive immune responses, and increased ocular and neuronal cell death that turns lethal for the infected mice. Furthermore, we find that mTORC2 mediated cell survival channels through the inactivation of the proapoptotic factor FoxO3a. Our results demonstrate how mTORC2 potentiates host defenses against viral infections and implicate mTORC2 as a necessary factor for survival of the infected host. |
format | Online Article Text |
id | pubmed-8516965 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-85169652021-10-29 mTORC2 confers neuroprotection and potentiates immunity during virus infection Suryawanshi, Rahul K. Patil, Chandrashekhar D. Agelidis, Alex Koganti, Raghuram Ames, Joshua M. Koujah, Lulia Yadavalli, Tejabhiram Madavaraju, Krishnaraju Shantz, Lisa M. Shukla, Deepak Nat Commun Article Herpes simplex virus type-1 (HSV-1) causes ocular and orofacial infections. In rare cases, HSV-1 can cause encephalitis, which leads to permanent brain injuries, memory loss or even death. Host factors protect humans from viral infections by activating the immune response. However, factors that confer neuroprotection during viral encephalitis are poorly understood. Here we show that mammalian target of rapamycin complex 2 (mTORC2) is essential for the survival of experimental animals after ocular HSV-1 infection in vivo. We find the loss of mTORC2 causes systemic HSV-1 infection due to defective innate and adaptive immune responses, and increased ocular and neuronal cell death that turns lethal for the infected mice. Furthermore, we find that mTORC2 mediated cell survival channels through the inactivation of the proapoptotic factor FoxO3a. Our results demonstrate how mTORC2 potentiates host defenses against viral infections and implicate mTORC2 as a necessary factor for survival of the infected host. Nature Publishing Group UK 2021-10-14 /pmc/articles/PMC8516965/ /pubmed/34650053 http://dx.doi.org/10.1038/s41467-021-26260-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Suryawanshi, Rahul K. Patil, Chandrashekhar D. Agelidis, Alex Koganti, Raghuram Ames, Joshua M. Koujah, Lulia Yadavalli, Tejabhiram Madavaraju, Krishnaraju Shantz, Lisa M. Shukla, Deepak mTORC2 confers neuroprotection and potentiates immunity during virus infection |
title | mTORC2 confers neuroprotection and potentiates immunity during virus infection |
title_full | mTORC2 confers neuroprotection and potentiates immunity during virus infection |
title_fullStr | mTORC2 confers neuroprotection and potentiates immunity during virus infection |
title_full_unstemmed | mTORC2 confers neuroprotection and potentiates immunity during virus infection |
title_short | mTORC2 confers neuroprotection and potentiates immunity during virus infection |
title_sort | mtorc2 confers neuroprotection and potentiates immunity during virus infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516965/ https://www.ncbi.nlm.nih.gov/pubmed/34650053 http://dx.doi.org/10.1038/s41467-021-26260-5 |
work_keys_str_mv | AT suryawanshirahulk mtorc2confersneuroprotectionandpotentiatesimmunityduringvirusinfection AT patilchandrashekhard mtorc2confersneuroprotectionandpotentiatesimmunityduringvirusinfection AT agelidisalex mtorc2confersneuroprotectionandpotentiatesimmunityduringvirusinfection AT kogantiraghuram mtorc2confersneuroprotectionandpotentiatesimmunityduringvirusinfection AT amesjoshuam mtorc2confersneuroprotectionandpotentiatesimmunityduringvirusinfection AT koujahlulia mtorc2confersneuroprotectionandpotentiatesimmunityduringvirusinfection AT yadavallitejabhiram mtorc2confersneuroprotectionandpotentiatesimmunityduringvirusinfection AT madavarajukrishnaraju mtorc2confersneuroprotectionandpotentiatesimmunityduringvirusinfection AT shantzlisam mtorc2confersneuroprotectionandpotentiatesimmunityduringvirusinfection AT shukladeepak mtorc2confersneuroprotectionandpotentiatesimmunityduringvirusinfection |